Cited by 110Attention Deficit Hyperactivity DisorderObsessive-Compulsive Spectrum DisordersSchizophrenia research and treatment

Adult ADHD and comorbid depression: A consensus-derived diagnostic algorithm for ADHD

Open access
Binder, Carin, McIntosh, Kutcher, Stan, Levitt, Rosenbluth, Fallu·2009·Neuropsychiatric Disease and Treatment

Abstract

OBJECTIVE: Many patients present to their physician with depression as their primary symptom. However, depression may mask other comorbid disorders. This article presents diagnostic criteria and treatment recommendations (and monitoring) pertaining to the diagnosis of adult attention deficit hyperactivity disorder (ADHD), which may be missed in patients who present with depressive symptoms, or major depressive disorder (MDD). Other co-occurring conditions such as anxiety, substance use, and bipolar disorder are briefly discussed. METHODS: A panel of psychiatrist-clinicians with expertise in the area of child and adolescent ADHD and mood disorders, adult mood disorders, and adult ADHD was convened. A literature search for recommendations on the diagnosis and treatment of co-occurring conditions (MDD, anxiety symptoms, and substance use) with adult ADHD was performed. Based on this, and the panel's clinical expertise, the authors developed a diagnostic algorithm and recommendations for the treatment of adult ADHD with co-occurring MDD. RESULTS: Little information exists to assist clinicians in diagnosing ADHD co-occurring with other disorders such as MDD. A three-step process was developed by the panel to aid in the screening and diagnosis of adult ADHD. In addition, comorbid MDD, bipolar disorder, anxiety symptoms, substance use and cardiovascular concerns regarding stimulant use are discussed. CONCLUSION: This article provides clinicians with a clinically relevant overview of the literature on comorbid ADHD and depression and offers a clinically useful diagnostic algorithm and treatment suggestions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2147/ndt.s4720

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Some existing ADHD medications have been associated with mood fluctuations that may exacerbate the severity of symptoms in patients with ADHD and comorbid anxiety or depression.

    “Treatment options that target symptoms of both ADHD and psychiatric comorbidities may be explored,10,28 taking into account potential drug-drug interactions or adverse effects of medications, as some existing ADHD medications have been associated with mood fluctuations that may exacerbate the severity of symptoms in patients with ADHD and comorbid anxiety or depression.7,10”

    From Health care resource utilization and costs associated with psychiatric comorbidities in adult patients with attention-deficit/ hyperactivity disorder (2024) · cites this paper as [10]

    In “ADHD with comorbid depression” (page not provided), the paper says ADHD medications may have behavioral side effects and advises monitoring the patient’s depressive state. It does not specifically report medication-associated mood fluctuations or say they exacerbate symptoms in patients with comorbid anxiety or depression. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 57

  1. [3]Biederman J Am J Psychiatry 1993 150 1792 1798 8238632
  2. [2]Bird HR Canino G Rubio-Stipec M Estimates of the prevalence of childhood maladjustment in a community survey in Puerto Rico Arch Gen Psychiatry 1988 45 1120 1126 3264147
  3. [3]Anderson JC Williams S McGee R DSM-III disorders in pre adolescent children: prevalence in a large sample from the general population Arch Gen Psychiatry 1987 44 69 76 2432848
  4. [4]Spencer T Biederman J Wilens TE Faraone SV Adults with attention-deficit/hyperactivity disorder; a controversial diagnosis J Clin Psychiatry 1998 59 Suppl 7 59 68 9680054
  5. [6]Cumyn L Kolar D Keller A Hechtman L Current issues and trends in the diagnosis and treatment of adults with ADHD Expert Rev Neurotherapeutics 2007 7 1375 1390 17939773
  6. [7]Alpert JA Maddocks A Nierenberg AA Attention deficit hyperactivity disorder in childhood among adults with major depression Psychiatry Res 2006 62 213 219 8804131
  7. [8]Kessler RC Adler L Barkley R The prevalence and correlates of Adult ADHD in the United States: results from the National Comorbidity Survey Replication Am J Psychiatry 2006 163 716 723 16585449 PMC2859678
  8. [9]Fayyad F De Graaf R Kessler R Cross–national prevalence and correlates of adult attention–deficit hyperactivity disorder Br J Psychiatry 2007 190 402 409 17470954
  9. [10]Mannuzza S Klein RG Klein DF Bessler A Shrout P Accuracy of adult recall of childhood attention deficit hyperactivity disorder Am J Psychiatry 2002 159 1882 1888 12411223
  10. [11]Faraone SV Biederman J Spencer T Diagnosing adult attention deficit hyperactivity disorder; are late onset and subthreshold diagnoses valid? Am J Psychiatry 2006 163 1720 1729 17012682
  11. [12]Asherson P Chen W Craddock B Taylor E Adult attention-deficit hyperactivity disorder: recognition and treatment in general adult psychiatry Br J Psychiatry 2007 190 4 5 17197649
  12. [13]Goodman DW The consequences of attention-deficit/hyperactivity disorder in adults J Psychiatr Pract 2007 13 318 327 17890980
  13. [15]Biederman J Impact of comorbidity in adults with attention-deficit/hyperactivity disorder J Clin Psychiatry 2004 65 Suppl 3 3 7 15046528
  14. [16]Murphy KR Adler LA Assessing attention-deficit/hyperactivity disorder in adults: focus on rating scales J Clin Psychiatry 2004 65 Suppl 3 12 17 15046530
  15. [17]Mannuzza S Klein RG Bessler A Malloy P LaPadula M Adult psychiatric status of hyperactive boys grown up Am J Psychiatry 1998 155 493 498 9545994
  16. [19]Barkley RA Fischer M Smallish L Fletcher K The persistence of attention deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder J Abnorm Psychol 2002 111 279 289 12003449
  17. [21]Rasmussen P Gillberg C Natural outcome of ADHD with developmental coordination disorder at age 22 years a controlled, longitudinal, community-based study J Am Acad Child Adolesc Psychiatry 2000 39 1424 1431 11068898
  18. [24]Able SL Johnston JA Adler LA Swindle RW Functional and psychosocial impairment in adults with undiagnosed ADHD Psychol Med 2007 37 97 107 16938146
  19. [26]Adler L Cohen J Diagnosis and evaluation of adults with attention- deficit/hyperactivity disorder Psychiatr Clin N Am 2004 27 187 201 15063992
  20. [27]Fischer M Barkley RA Smallish L Fletcher K Executive functioning in hyperactive children as young adults: attention, inhibition, response perseveration, and the impact of comorbidity Dev Neuropsychol 2005 27 107 133 15737944
  21. [28]Nadeau K Career choices and workplace challenges for individuals with ADHD J Clin Psychiatry 2005 61 549 563 15723424
  22. [29]Adler L Cohen J Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder Psychiatr Clin North Am 2004 27 187 201 15063992
  23. [30]Biederman J Faraone S Spencer T Functional impairments in adults with self-reports of diagnosed ADHD: a controlled study of 1001 adults in the community J Clin Psychiatry 2006 67 524 540 16669717
  24. [31]Barkley RA Fischer M Edelbrock CS The adolescent outcome of hyperactive children diagnosed by research criteria: I. An 8-year prospective follow-up study J Am Acad Child Adolesc Psychiatry 1990 29 546 557 2387789
  25. [32]Clarke S Heussler H Kohn M Attention deficit disorder: not just for children Int Med J 2005 35 721 725 16313548
  26. [35]Cantwell D Hanna G Attention deficit hyperactivity disorder Tasman A Hales R Frances A Review of Psychiatry, 8 Washington, DC American Psychiatric Press 1989 134 161
  27. [38]Faraone SV Genetics of childhood disorders: XX. ADHD, Part 4: IS ADHD genetically heterogeneous? J Am Acad Child Adolesc Psychiatry 2000 39 1455 1457 11068903
  28. [39]Faraone SV Biederman J Monuteaux M Toward guidelines for pedigree selection in genetic studies of attention deficit hyperactivity disorder Genet Epidemiol 2000 18 1 16 10603455
  29. [40]Faraone SV Biederman J Do attention deficit hyperactivity disorder and major depression share familial risk factors? J Nerv Ment Dis 1997 185 533 541 9307614
  30. [41]Moss SB Nair R Vallarino A Wang S Attention deficit/hyperactivity disorder in adults Prim Care Clin Office Pract 2007 34 445 473 17868755
  31. [42]Biederman J Attention-deficit/hyperactivity disorder: a life-span perspective J Clin Psychiatry 1998 59 Suppl 7 4 16 9680048
  32. [44]Milberger S Biederman J Faraone SV Murphy J Tsuang MT Attention deficit hyperactivity disorder and comorbid disorders: Issues of overlapping symptoms Am J Psychiatry 1995 152 1793 1799 8526248
  33. [45]Fischer M Barkley R Smallish L Fletcher K Young adult follow-up of hyperactive children: Self-reported psychiatric disorders, comorbidity, and the role of childhood conduct problems and teen CD J Abnormal Child Psychol 2002 60 463 475 12403150
  34. [47]Katz LJ Wood DS Goldstein G Auchenbach RC Geckle M The utility of neuropsychological tests in evaluation of attention-deficit hyperactivity disorder (ADHD) versus depression in adults Assessment 1998 5 45 51 9458341
  35. [48]Rostain AL Adult ADHD and depressive disorders: prevalence, significance and clinical presentation CNS Spectr 2008 13 5 Suppl 8 8 10 18567132
  36. [49]Sobanski E Bruggeman D Alm B Psychiatric comorbidity and functional impairment in a clinically referred sample of adults with attention-deficit/hyperactivity disorder (ADHD) Eur Arch Psychiatry Clin Neurosci 2007 257 371 377 17902010
  37. [50]Biederman J Faraone SV Spencer T Wilens T Mick B Lapey B Gender differences in adults with attention-deficit hyperactivity disorder Psychiatry Res 1994 53 13 29 7991729
  38. [51]Lewinsohn PM Rohde P Seeley JR Psychosocial characteristics of adolescents with a history of suicide attempt J Am Acad Child Adolesc Psychiatry 1993 32 60 68 8428885
  39. [52]Fischer AG Bau CHD Grevet EH The role of comorbid major depressive disorder in the clinical presentation of adult ADHD J Psychiatr Res 2007 41 991 996 17098256
  40. [54]Biederman J Faraone SV Monuteaux MC Bober M Cadogen E Gender effects on attention-deficit/hyperactivity disorder in adults, revisited Biol Psychiatry 2004 55 692 700 15038997
  41. [56]Blackman GL Ostrander R Herman KC Children with ADHD and depression: a multisource, multimethod assessment of clinical, social and academic functioning J Atten Disord 2005 8 195 207 16110050
  42. [57]Brent DA Perper JA Goldstein CE Risk factors for adolescent suicide Arch Gen Psychiatry 1988 45 581 588 3377645
  43. [58]Biederman J Faraone SV Keenan K Tsuang MT Evidence of familial association between attention deficit disorder and major affective disorders Arch Gen Psychiatry 1991 48 633 642 2069494
  44. [60]Biederman J Mick E Faraone SV Depression in attention deficit hyperactivity disorder (ADHD) children: “true” depression or demoralization? J Affect Disord 1998 47 113 122 9476751
  45. [61]Clarke DM Kissane DW Demoralization: its phenomenology and importance Aust N Z J Psychiatry 2002 36 733 742 12406115
  46. [64]Kolar D Keller A Golfinopoulos M Cumyn L Syer C Hechtman L Treatment of adults with attention-deficit/hyperactivity disorder Neuropsychiatr Dis Treat 2008 4 389 403 18728745 PMC2518387
  47. [65]Gibbins C Weiss M Clinical recommendations in current practice guidelines for diagnosis and treatment of ADHD in adults Curr Psychiatry Rep 2007 9 420 426 17915083
  48. [66]Hornig-Rohan M Amsterdam JD Venlafaxine versus stimulant therapy in patietns with dual diagnosis ADD and depression Progr NeuroPsychopharmacol Biol Psychiatry 2002 26 585 589 11999912
  49. [68]Myronuk LDS Weiss M Combined treatment with moclobemide and methylphenidate for comorbid major depression and adult attention-deficit/hyperactivity disorder J Clin Psychopharmacol 16 468 469 8959481
  50. [69]Findling RL Open-label treatment of comorbid depression and attentional disorders with co-administration of serotonin reuptake inhibitors and psychostimulants in children, adolescents and adults J Child Adolesc Psychopharmacol 1996 6 165 175 9231310
  51. [70]Spencer TJ Treatment of adult ADHD and comorbid depression CNS Spectr 2008 13 Suppl 8 14 16 18567134
  52. [76]Wigal SB Wigal TL Special considerations in diagnosing and treating attention-deficit/hyperactivity disorder CNS Spectr. 2007 12 6 Suppl 9 1 14 17545959
  53. [77]Faraone SV Wilens T Does stimulant treatment lead to substance abuse disorders? J Clin Psychiatry 2003 64 Suppl 11 9 13 14529324
  54. [80]McCracken JT Biederman J Greenhill LL Analog classroom assessment of a once-daily mixed amphetamine formulation, SlI381 (Adderall XR) in children with ADHD J Am Acad Child Adolesc Psychiatry 2003 42 673 683 12921475
  55. [81]Michelson D Adler L Spencer T Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies Biol Psychiatry 2003 53 112 120 12547466
  56. [82]American Heart Association, American Academy of PediatricsClarification of statement on cardiovascular evaluation and monitoring of children and adolescents with heart disease receiving medications for ADHD [Press Release]. May 16, 2008. Cited Dec 12, 2008. Available from: http://circ.ahajournals.org/cgi/content/full/CIRCULATIONAHA.107.189473/DC1 18698199
  57. [83]Wooltorton E Medications for attention deficit hyperactivity disorder: cardiovascular concerns CMAJ 2006 175 2 PMC1482769 16772535

Cited by

Sorted by citations

Authors
Binder, C., McIntosh, Kutcher, S., Levitt, Rosenbluth, & Fallu
Affiliations
  • Janssen Canada (Canada) (CA)
  • Dalhousie University (CA)
  • Sunnybrook Health Science Centre (CA)
  • University of Toronto (CA)
Venue
Neuropsychiatric Disease and Treatment
Published
2009-03
Volume
5
Pages
137
ISSN
1176-6328 (ISSN-L)
OpenAlex
W1970848658
Cited by
110
References
18
Citations by year
2026: 6 · 2025: 16 · 2024: 6 · 2023: 7 · 2022: 7 · 2021: 8 · 2020: 8 · 2019: 9 · 2018: 5 · 2017: 6 · 2016: 7 · 2015: 5 · 2014: 4 · 2013: 6 · 2012: 3
FWCI
1.96
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Neuropsychiatric Disease and Treatment (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, other-oa)
  • PubMed (publishedVersion)
  • Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
Funders
  • Eli Lilly and Company
  • GlaxoSmithKline
  • Sanofi
  • Servier
  • H. Lundbeck A/S
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
adult ADHD, comorbid depression, major depressive disorder, diagnostic algorithm, ADHD screening, bipolar disorder, anxiety symptoms, substance use, stimulant use, cardiovascular risk, treatment guidelines, consensus panel

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review